Key facts
- Notable investors include Chengshu Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Innoray Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Innoray Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Innoray Medical
Developer of a medical technology platform designed to advance comprehensive bone metabolism management across all stages of life. The company offers AI-powered diagnostic systems, tiered treatment models, and proprietary imaging tools, enabling hospitals, research institutions, and community clinics to enhance precision in osteoporosis care and personalized skeletal health monitoring.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2022
- Website
- innoray-healthcare.com/
- Ownership
- Privately Held (backing)
Innoray Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innoray Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innoray Medical in its N-PORT filings yet. We sweep new filings monthly.